Ultrasound‐Responsive Carbon Monoxide Microneedle for Enhanced Healing of Infected Diabetic Wounds

Abstract

Efficient management of difficult‐to‐heal diabetic wounds remains a clinical challenge owing to bacterial infections, as well as oxidative and hyperglycemic complex pathology. Therefore, developing intelligent strategies for diabetic wound healing is urgently needed. Herein, an ultrasound (US)‐responsive microneedle (MN) patch (MN@GOX@TiO2‐X@CO) capable of controlled delivery of carbon monoxide (CO) gas within the skin for effective treatment of diabetic infected wounds is developed. Benefiting from the specific form of microneedle (MN) patch, sonosensitizer (TiO2‐X), •OH‐responsive CO prodrug (MPA‐CO), and glucose oxidase (GOX) can be loaded together and effectively delivered to infectious wounds. With the semi‐fluidic hyaluronic acid (HA) coating under the physiological condition, CO could be released efficiently in situ and directly acted on infected wound tissue upon US triggering. Both in vitro and in vivo results showed that US‐triggered CO release from MN@GOX@TiO2‐X@CO not only effectively inhibited the S. aureus and MRSA infection but also promoted fibroblasts proliferation and migration under hyperglycemic physiology, thereby accelerating diabetic wound healing. Collectively, the approach effectively addresses the impaired skin regeneration function in diabetic wounds and offers a promising therapeutic strategy for the efficient healing of infected diabetic wounds.